Literature DB >> 3138110

Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies.

J L Dangl1, T G Wensel, S L Morrison, L Stryer, L A Herzenberg, V T Oi.   

Abstract

We generated a family of chimeric immunoglobulin G (IgG) molecules having identical antigen-combining sites for the dansyl (DNS) hapten, in conjunction with nine heavy chain constant (CH) regions. This family of antibody molecules allows comparison of CH dependent properties independent of possible variable region contributions to IgG function. The segmental flexibility and complement fixation activity were measured of six genetically engineered molecules (the four human IgG isotypes, mouse IgG3 and rabbit IgG) and the remaining three mouse IgG isotypes, (IgG1, IgG2a and IgG2b), isolated previously by somatic cell genetic techniques. These properties of antibody molecules each correlate with the length of the immunoglobulin hinge region which separate the first and second CH (CH1 and CH2) domains. These results attribute a structural basis for two critical properties of antibody molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138110      PMCID: PMC454472          DOI: 10.1002/j.1460-2075.1988.tb03037.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  The structural basis for the functional versatility of immunoglobulin G1.

Authors:  K J Dorrington
Journal:  Can J Biochem       Date:  1978-12

2.  MOLECULAR MECHANISM OF FORMATION OF AN ANTIGEN-ANTIBODY COMPLEX.

Authors:  A FEINSTEIN; A J ROWE
Journal:  Nature       Date:  1965-01-09       Impact factor: 49.962

3.  Crystallographic structure studies of an IgG molecule and an Fc fragment.

Authors:  R Huber; J Deisenhofer; P M Colman; M Matsushima; W Palm
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

4.  Electron microscopy of an antibody-hapten complex.

Authors:  R C Valentine; N M Green
Journal:  J Mol Biol       Date:  1967-08-14       Impact factor: 5.469

Review 5.  Three-dimensional structure of immunoglobulins.

Authors:  L M Amzel; R J Poljak
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

Review 6.  Structure and function of the constant regions of immunoglobulins.

Authors:  D Beale; A Feinstein
Journal:  Q Rev Biophys       Date:  1976-05       Impact factor: 5.318

7.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.

Authors:  D E Isenman; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

9.  Effect of tunicamycin on IgM, IgA, and IgG secretion by mouse plasmacytoma cells.

Authors:  S Hickman; S Kornfeld
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

10.  Three-dimensional structure of an intact human immunoglobulin.

Authors:  E W Silverton; M A Navia; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

View more
  81 in total

1.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

3.  A spectrophotometric method to precisely determine endpoint titers in complement fixation assays.

Authors:  Ryan J Welch; Stephen D Merrigan; Julio C Delgado
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

4.  Antibody organization on lipid films. Influence of pH and interchain disulphide reduction.

Authors:  E E Uzgiris
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

5.  Nanosecond fluorescence microscopy. Emission kinetics of fura-2 in single cells.

Authors:  S M Keating; T G Wensel
Journal:  Biophys J       Date:  1991-01       Impact factor: 4.033

6.  Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.

Authors:  Zhaohua Lu; Marly I Roche; Julia H Hui; Berkay Unal; Philip L Felgner; Sunita Gulati; Guillermo Madico; Jacqueline Sharon
Journal:  Immunol Lett       Date:  2007-08-08       Impact factor: 3.685

7.  Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability.

Authors:  Joshua D Ramsey; Michelle L Gill; Tim J Kamerzell; E Shane Price; Sangeeta B Joshi; Steven M Bishop; Cynthia N Oliver; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2009-07       Impact factor: 3.534

8.  Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.

Authors:  C L Harris; A S Williams; S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.

Authors:  M J Preston; A A Gerçeker; M E Reff; G B Pier
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Expanding the Scope of Antibody Rebridging with New Pyridazinedione-TCO Constructs.

Authors:  Angela N Marquard; Jonathan C T Carlson; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2020-04-28       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.